Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-23-020346

VP and Chief Compliance Office gave up 1,280 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Herman James L VP and Chief Compliance Office 2023-03-18 Shares withheld for taxes −1,280 $1.92 $2,458 39,441 D
Loading xslF345X04/doc4.xml…